Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.
Int J Cancer. 2020 Sep 1;147(5):1427-1436. doi: 10.1002/ijc.32897. Epub 2020 Feb 19.
We have investigated the prognostic value of two novel interim F-fluorodeoxyglucose positron emission tomography (FDG-PET) parameters in patients undergoing chemoradiation (CRT) for esophageal squamous cell carcinoma (ESCC): one tumor parameter (maximal standardized uptake ratio rSUR) and one normal tissue parameter (change of FDG uptake within irradiated nontumor-affected esophagus ∆SUV ). PET data of 134 European and Chinese patients were analyzed. Parameter establishment was based on 36 patients undergoing preoperative CRT plus surgery, validation was performed in 98 patients receiving definitive CRT. Patients received PET imaging prior and during fourth week of CRT. Clinical parameters, baseline PET parameters, and interim PET parameters (rSUR and ∆SUV ) were analyzed and compared to event-free survival (EFS), overall survival (OS), loco-regional control (LRC) and freedom from distant metastases (FFDM). Combining rSUR and ∆SUV revealed a strong prognostic impact on EFS, OS, LRC and FFDM in patients undergoing preoperative CRT. In the definitive CRT cohort, univariate analysis with respect to EFS revealed several staging plus both previously established interim PET parameters as significant prognostic factors. Multivariate analyses revealed only rSUR and ∆SUV as independent prognostic factors (p = 0.003, p = 0.008). Combination of these parameters with the cutoff established in preoperative CRT revealed excellent discrimination of patients with a long or short EFS (73% vs. 17% at 2 years, respectively) and significantly discriminated all other endpoints (OS, p < 0.001; LRC, p < 0.001; FFDM, p = 0.02), even in subgroups. Combined use of interim FDG-PET derived parameters ∆SUV and rSUR seems to have predictive potential, allowing to select responders for definitive CRT and omission of surgery.
我们研究了两种新型氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)参数在接受放化疗(CRT)的食管鳞状细胞癌(ESCC)患者中的预后价值:一个肿瘤参数(最大标准化摄取比值 rSUR)和一个正常组织参数(受照非肿瘤受累食管内 FDG 摄取的变化 ∆SUV)。分析了 134 名欧洲和中国患者的 PET 数据。参数建立基于 36 名接受术前 CRT 加手术的患者,验证在 98 名接受确定性 CRT 的患者中进行。患者在 CRT 前和第 4 周进行 PET 成像。分析并比较了临床参数、基线 PET 参数和中期 PET 参数(rSUR 和 ∆SUV)与无事件生存(EFS)、总生存(OS)、局部区域控制(LRC)和无远处转移(FFDM)。rSUR 和 ∆SUV 的联合使用对接受术前 CRT 的患者的 EFS、OS、LRC 和 FFDM 具有强烈的预后影响。在确定性 CRT 队列中,EFS 的单因素分析显示,几个分期加上之前建立的中期 PET 参数都是重要的预后因素。多因素分析显示,只有 rSUR 和 ∆SUV 是独立的预后因素(p=0.003,p=0.008)。这些参数与术前 CRT 中建立的截定点相结合,可极好地区分 EFS 长或短的患者(分别为 2 年时 73%和 17%),并显著区分所有其他终点(OS,p<0.001;LRC,p<0.001;FFDM,p=0.02),即使在亚组中也是如此。联合使用中期 FDG-PET 衍生参数 ∆SUV 和 rSUR 似乎具有预测潜力,可选择适合确定性 CRT 的应答者,并避免手术。